MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1513/annalsats.202311-962oc

Медицинская библиотека · Annals of the American Thoracic Society · 2024

Measuring Quality-weighted Hospital-Free Days in Acute Respiratory Failure: A Modified Delphi Study.

Auriemma Catherine L, Butt Maayra I, Bahti Melanie, Silvestri Jasmine A, Solomon Ellen, Harhay Michael O, Klaiman Tamar, Schapira Marilyn M, Barg Frances K, Halpern Scott D

СтатьяПоддержка NIH: внешняя программаПеревод пока не подготовлен

Аннотация

Rationale: Hospital-free days (HFDs), a measure of the number of days alive spent outside the hospital, is increasingly used as an endpoint in studies of patients with acute respiratory failure (ARF) or other critical and serious illnesses. Current approaches to measuring HFDs do not account for decrements in functional status or quality of life that ARF survivors and family members value.

Objectives

To develop an acceptable approach to measure quality-weighted HFDs using patient-reported outcomes.

Methods

We conducted a four-round modified Delphi process among ARF experts: those with lived or professional experience. Experts rated survivorship domains, instrument and data collection characteristics, and methods to translate responses into quality-weighted HFDs. The consensus threshold was that ⩾70% of respondents rated an item "totally acceptable" or "acceptable" and ⩽15% of respondents rated the item "totally unacceptable," "unacceptable," or "slightly unacceptable."

Results

Fifty-seven experts participated in round 1. Response rates were 82-93% for subsequent rounds. Priority survivorship domains were physical function and health-related quality of life. Participants reached a consensus that data collection during ARF recovery should take less than 15 minutes per assessment, allow surrogate completion when patients are unable, and continue for at least 24 months of follow-up. Using the EuroQol-5 Dimensions (EQ-5D) questionnaire to quality weight HFDs met consensus criteria for acceptability. A majority of panelists preferred quality-weighted HFDs to unweighted HFDs or survival for use in future ARF studies.

Conclusions

Quality-weighting HFDs using patient and/or surrogate responses to the EQ-5D captured stakeholder priorities and was acceptable to this Delphi panel.

Для цитирования: Auriemma Catherine L, Butt Maayra I, Bahti Melanie, Silvestri Jasmine A, Solomon Ellen, Harhay Michael O, Klaiman Tamar, Schapira Marilyn M, Barg Frances K, Halpern Scott D. Measuring Quality-weighted Hospital-Free Days in Acute Respiratory Failure: A Modified Delphi Study.. Annals of the American Thoracic Society. 2024. DOI: 10.1513/annalsats.202311-962oc.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.